Advertisement
![Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px](/banner/swiss-biotech-association-20250115-650-100-swiss-biotech-day-2025-basel.jpg)
Product › Details
genomics
![]() |
Next higher product group | genomics/genetics |
Record changed: 2024-11-24 |
Advertisement
![Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px](/banner/swiss-biotech-association-20250115-650-200-swiss-biotech-day-2025-basel.jpg)
More documents for genomics
- [1] Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA....
- [2] WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA....
- [3] Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA....
- [4] Illumina, Inc.. (10/11/22). "Press Release: Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery". San Diego, CA....
- [5] Illumina, Inc.. (6/28/22). "Press Release: Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health". San Diego, CA....
- [6] Novo Nordisk Foundation. (9/15/21). "Press Release: Novo Nordisk Foundation and Broad Institute of MIT and Harvard Launch New Research Center for Genomic Mechanisms of Disease". Cambridge, MA & Copenhagen....
- [7] Depixus SAS. (3/22/21). "Press Release: Depixus Announces Peer-reviewed Publication Describing the Detection of Sequence Variation and Base Modifications on DNA and RNA Using Its Novel MAGNA Technology". Paris & Cambridge....
- [8] Bruker Corporation. (3/18/21). "Press Release: Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics". San José, CA & Boston, MA....
- [9] Dyne Therapeutics Inc.. (5/19/20). "Press Release: Dyne Therapeutics Accelerates Programs in Facioscapulohumeral Muscular Dystrophy (FSHD) with Exclusive Licensing of Technologies to Target Genetic Basis of FSHD and Expanded Scientific Advisory Board". W...
- [10] Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
![Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x300px](/banner/berlin-partner-20241220-650-300-regmedforum-2025-event-february-health-capital.jpg)
» top